4//SEC Filing
Lynch Zack 4
Accession 0001062993-21-012390
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:23 PM ET
Size
11.7 KB
Accession
0001062993-21-012390
Insider Transaction Report
Form 4
Lynch Zack
Director
Transactions
- Award
Class A Common Stock
2021-12-03+9,671,673→ 9,671,673 total(indirect: by JAZZ Human Performance Technology Fund, L.P.) - Award
Class A Common Stock
2021-12-03$10.00/sh+10,000$100,000→ 9,681,673 total(indirect: by JAZZ Human Performance Technology Fund, L.P.) - Award
Class A Common Stock
2021-12-03+1,084,914→ 1,084,914 total(indirect: by JAZZ Human Performance Opportunity Fund, L.P.) - Award
Stock Option (Right to Buy)
2021-12-03+29,448→ 29,448 totalExercise: $0.02Exp: 2025-01-21→ Common Stock (29,448 underlying)
Footnotes (6)
- [F1]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 736,827 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Opportunity Fund, L.P.
- [F2]Received in accordance with the terms of the Business Combination Agreement in exchange for 6,568,585 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Technology Fund, L.P.
- [F3]The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of the Reporting Person's pecuniary interest therein.
- [F4]On June 21, 2021, Issuer entered into subscription agreements with certain investors (the "PIPE Investors") pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $10.00 per share in connection with, and conditioned upon, the substantially concurrent consummation of certain transactions, including the Business Combination. As one of the PIPE Investors, on December 3, 2021, JAZZ Human Performance Technology Fund, L.P. acquired 10,000 shares of Issuer common stock for $10.00 per share.
- [F5]100% of the shares subject to this option are fully vested and exercisable.
- [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 20,000 shares of common stock of Private Pear for $0.02 per share.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881044
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:23 PM ET
- Size
- 11.7 KB